Founded in 2009, Qilu Synva Pharmaceutical Co., Ltd. is currently the largest domestic base of manufacturing cephalosporin BPC for animals. Its ceftiofur and cefquinome BPCs in particular are ranking No.1 in China in terms of market share and annual production capacity. The Company offers outstanding veterinary BPCs and preparations and quality services for global animal husbandry and makes itself a world-class haute animal health brand.
Number of employees
Number of patents obtained
Committed to the cause of animal protection, caring for human health
The company always adheres to innovation-driven development and attaches great importance to the building of independent innovation capabilities of the enterprise. Currently, it has authorized 20 invention patents, has 19 national new veterinary drugs, has been approved for 32 production numbers, and many products are exclusively produced in China. The company has undertaken more than 30 scientific research tasks at or above the provincial level. Many projects have won the Shennong China Agricultural Science and Technology Award, Shandong Science and Technology Progress Award and Dezhou Science and Technology Progress Award. It has also established Shandong Engineering Technology Research Center for Veterinary Chemicals and Shandong Province. Green and low-toxicity veterinary pharmaceutical engineering laboratory, Shandong Enterprise Technology Center and other scientific and technological innovation platforms. The company has successively won the honorary titles of National High-tech Enterprise, Shandong Top 100 High-tech Enterprise Innovation Capability Enterprise, Shandong Gazelle Enterprise, and 2020 National Pesticide Industry Sales Top 100.
Committed to animal protection, caring for human health